Patents
Patents for C07C 229 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton (21,416)
07/2010
07/20/2010US7759502 Stilbene derivatives and their use for binding and imaging amyloid plaques
07/20/2010US7759452 Adhesive, sealant and coating compositions containing polyesters, polyethers, polyurethanes, polyureas, or acrylic polymers functionalized with dialkyl aziridin-1-ylaspartates and mixed with a polyisocyanate; used for bonding wood, metals, plastics, paper, canvas, ceramics, stone, glass, and concrete
07/20/2010US7759394 Diclofenac formulations and methods of use
07/20/2010US7759392 4-nitroxybutyric acid ester derivatives of drugs such as acetaminophen, having an improved therapeutic index (efficacy/toxicity ratio) or a lower risk/benefit ratio, usedfor treating oxidative stress and endothelian dysfunctions, inflammation and pain
07/20/2010US7759285 Absorbent for separation of carbon dioxide
07/20/2010CA2486399C Calcium receptor modulating agents
07/20/2010CA2329659C Perfluorinated esters of alkanoyl l-carnitine for the preparation of cationic lipids for the intracellular delivery of pharmacologically active compounds
07/15/2010WO2010079668A1 Olefin compound
07/15/2010WO2010042759A3 Gaba conjugates and methods of use thereof
07/15/2010US20100179216 Amine compound and pharmaceutical use thereof
07/15/2010US20100178324 Composition and method for the treatment of diseases affected by apoptosis
07/14/2010CN101778815A Method of producing optically active n-(halopropyl)amino acid derivative
07/14/2010CN101774935A Method for separating and purifying L-ornithine by using simulated moving bed
07/14/2010CN101774934A Method for synthesizing lauroyl L-carnitine hydrochloride
07/14/2010CN101139299B Method for preparing copper zinc aminoacetic acid complex by ball milling solid state
07/13/2010US7754898 Method of enantioselective nucleophilic addition reaction of enamide to imine and synthesis method of α-amino-γ-keto acid ester
07/13/2010US7754772 (2R)-2,3-bis(nitrooxy)propyl(2S)-2(6-methoxy(2-naphthyl)propanoate, used for treating inflammation, pain and fever; gastrointestinal disorders; wound healing agents; preventing gastrointestinal, renal and/or respiratory toxicities; side effect reduction
07/13/2010US7754654 Substituted spirocyclic ketoenols
07/08/2010WO2010075937A1 Monohydrate of 4-({(4-carboxybutyl)[2-(2-{[4-(2-phenylethyl)benzyl]oxy}phenyl)ethyl]-amino}methyl)benzoic acid
07/08/2010WO2010075930A1 Modification i of 4-({4-carboxybutyl)[2-(2-{[4-(2-phenylethyl)benzyl]oxy}phenyl)ethyl]-amino}methyl)benzoic acid
07/08/2010WO2010062590A3 Process for the preparation of protected l-alanine derivatives
07/08/2010US20100174084 2-Alkoxy-6-alkyl-phenyl-substituted Spirocyclic Tetramic Acid Derivatives
07/08/2010US20100173994 Synthesis of triethylenetetramines
07/08/2010US20100173993 Controlled release biocidal salts
07/08/2010US20100173992 Levodopa dimethyl-substituted diester prodrugs, compositions, and methods of use
07/08/2010US20100173955 4-substituted phenoxyphenylacetic acid derivatives
07/08/2010US20100173780 Polyphenol-content-increasing agent for plant
07/08/2010US20100173775 Herbicidally and insecticidally active 4-phenyl-substituted pyridazinones
07/08/2010US20100172916 Substituted hydroxyphenylamine compounds
07/08/2010CA2746871A1 Monohydrate of 4-({(4-carboxybutyl)[2-(2-{[4-(2-phenylethyl)benzyl]oxy}phenyl)ethyl]-amino}methyl)benzoic acid
07/08/2010CA2746870A1 Modification i of 4-({4-carboxybutyl)[2-(2-{[4-(2-phenylethyl)benzyl]oxy}phenyl)ethyl]-amino}methyl)benzoic acid
07/07/2010EP2204648A1 Method of stabilizing hem protein and storage solution therefor
07/07/2010EP2203487A1 Method for preparing polymer materials doped with metal elements and resulting materials
07/07/2010EP2203411A2 N-phenyl anthranilic acid derivatives and uses thereof
07/07/2010EP2203410A1 Method for producing 4-aminobut-2-enolides
07/07/2010CN101768149A Novel beta- aminoketone (alkamine) derivatives and use thereof
07/06/2010US7750185 Photoactive materials
07/06/2010US7750181 Antiproliferative agents
07/01/2010WO2010072727A1 New retinoid derivatives endowed with cytotoxic and/or antiangiogenic properties
07/01/2010WO2010071988A1 Plasmalogen compounds, pharmaceutical compositions containing the same and methods for treating diseases of the aging
07/01/2010US20100168468 Wrinkle-preventing and improving composition
07/01/2010US20100168453 Method for the synthesis of omega-amino-alkanoic acids
07/01/2010US20100168198 Mitochondria-targeted antioxidant prodrugs and methods of use
07/01/2010US20100168079 Biaryl Benzylamine Derivatives
07/01/2010US20100168068 Mao-b inhibitors useful for treating obesity
07/01/2010US20100168040 Muscle fatigue remedy
07/01/2010US20100167995 Peptoid compounds
07/01/2010CA2746831A1 Plasmalogen compounds, pharmaceutical compositions containing the same and methods for treating diseases of the aging
07/01/2010CA2740928A1 New retinoid derivatives endowed with cytotoxic and/or antiangiogenic properties
06/2010
06/30/2010EP2200981A1 Novel carbamoylglycine derivatives
06/30/2010CN101765617A Compound, method for producing the same, ink composition using the compound, thin film, organic transistor, and organic electroluminescent device
06/30/2010CN101762137A technology for drying d-(-)-p-hydroxyphenylglycine
06/30/2010CN101759623A (R) - amino acid schiff base complex and preparation method and application thereof
06/30/2010CN101759622A Novel amino Schiff base complex and preparation method and application thereof
06/30/2010CN101759621A (S)-amino acid Schiff base coordination compound, preparation method and application thereof
06/30/2010CN101759610A Salt coagulation technology for hydrolyzed L-(+)-p-hydroxyphenylglycine-p-toluenesulfonate mother liquor
06/30/2010CN101759609A Technology for purifying D-(-)-p-hydroxyphenylglycine-p-toluenesulfonate
06/30/2010CN101759608A Racemization technology for D-(-)-p-hydroxyphenylglycine-p-toluenesulfonate
06/30/2010CN101759607A Salt coagulation technology for hydrolyzed D-(-)-p-hydroxyphenylglycine-p-methylbenzenesulfonate mother liquor
06/30/2010CN101759606A Deep crystallization technology for purified D-(-)-p-hydroxyphenylglycine-p-toluenesulfonate mother liquor
06/30/2010CN101759589A Technology for producing DL-p-hydroxyphenylglycine-o-toluenesulfonate
06/30/2010CN101759588A Salt coagulation technology for DL-p-hydroxyphenylglycine
06/30/2010CN101759587A Technology for splitting DL-p-hydroxyphenylglycine-o-toluenesulfonate
06/30/2010CN101759586A Technology for purifying L-(+)-p-hydroxyphenylglycine-p-toluenesulfonate
06/30/2010CN101759585A Deep crystallization technology for purified L-(+)-p-hydroxyphenylglycine-p-toluenesulfonate mother liquor
06/30/2010CN101759584A Technology for purifying DL-p-hydroxyphenylglycine
06/30/2010CN101759583A New technology for recycling DL-p-hydroxyphenylglycine waste
06/30/2010CN101759582A New process for producing DL-p-hydroxyphenylglycine
06/30/2010CN101759581A Technology for recycling D--)-p-hydroxy-alpha(3-methoxyl-1-methyl-3-oxo-allyl)amino potassium acetate synthetic mother liquor
06/30/2010CN101759580A Method for preparing threonine crystal by threonine fermentation liquid
06/30/2010CN101759579A Technology for hydrolyzing D-(-)-p-hydroxyphenylglycine-p-toluenesulfonate
06/30/2010CN101759578A Method for recovering useful ingredients in waste glycin mother liquor
06/30/2010CN101759200A Technology for treating DL-p-hydroxyphenylglycine synthetic mother liquor
06/29/2010US7745663 mitogen-activated protein kinase inhibitors such as 3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-N-(2-hydroxy-ethoxy)-5(2-hydroxy-ethoxymethyl)-benzamide, used to treat proliferative diseases, for example, cancers, psoriasis, restenosis, autoimmune diseases and atherosclerosis
06/29/2010US7745652 Integrated chemical processes for industrial utilization of seed oils
06/29/2010US7745651 liposomes; nucleic acid lipid particles; gene therapy; improved membrane fluidity
06/29/2010US7745489 Potent 2-oxo-amide based compounds; abrogating prostaglandin production; low dosage; spinal cord and central nervous system pain
06/29/2010US7745439 Indene derivatives and process for the preparation thereof
06/29/2010CA2453516C Alpha-ketoglutarates of l-carnitine and alkanoyl l-carnitine and compositions thereof
06/29/2010CA2399501C A process for the preparation of salts of l-carnitine and alkanoyl l-carnitine with mucic acid
06/24/2010WO2010070368A1 Process for the preparation of trans 4-amino-cyclohexyl acetic acid ethyl ester hcl
06/24/2010WO2010070228A1 Process for the ammonolysis of 11-bromoundecanoic acid
06/24/2010WO2010069397A1 Process for the preparation of diclofenac epolamine
06/24/2010WO2009101616A9 Novel conjugates for treating neurodegenerative diseases and disorders
06/24/2010US20100160482 Ophthalmologic Composition And Ophthalmologic Lens
06/24/2010US20100160285 Biphenyloxyacetic Acid Derivatives for the Treatment of Respiratory Disease
06/24/2010US20100160248 Isotopically modified compounds and their use as food supplements
06/24/2010US20100159593 Transfection reagents
06/24/2010US20100159501 Method for quantification of cellular sphingolipids
06/24/2010US20100158996 Ester compound and medical use thereof
06/24/2010DE102008062689A1 Modifikation I der 4-({(4-Carboxybutyl)[2-(2-{[4-(2-phenylethyl)benzyl]oxy}phenyl)ethyl]-amino}methyl)benzoesäure Modification I of the 4 - ({(4-carboxybutyl) [2- (2 - {[4- (2-phenylethyl) benzyl] oxy} phenyl) ethyl] amino} methyl) benzoic acid
06/24/2010DE102008062688A1 Monohydrat der 4-({(4-Carboxybutyl)[2-(2-{[4-(2-phenylethyl)benzyl]oxy}phenyl)ethyl]-amino}methyl)benzoesäure Benzoic acid monohydrate of 4 - - (methyl amino {(4-carboxybutyl) [{[4- (2-phenylethyl) benzyl] oxy} phenyl) ethyl 2- (2]})
06/24/2010CA2743921A1 Process for the preparation of trans 4-amino-cyclohexyl acetic acid ethyl ester hcl
06/23/2010EP2199275A1 Inhibitor of ischemic disorders
06/23/2010EP2197833A1 Branched polyesteramine acrylate
06/23/2010CN101747222A Glycine chelate oyster calcium aqueous synthesis method and preparation of high-calcium soy
06/23/2010CN101747221A Method for preparing amino adamantane carboxylic acid compounds
06/23/2010CN101747220A Novel method for synthesizing methyldopate hydrochloride
06/23/2010CN101747219A Synthesis of clopidogrel impurity intermediate
06/23/2010CN101747218A Method for removing impurities in glycine synthetic process
1 ... 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 ... 215